Article metrics
PDF
Other content recommended for you
- Ethics and ego dissolution: the case of psilocybin
- Supple bodies, healthy minds: yoga, psychedelics and American mental health
- Psychedelic injustice: should bioethics tune in to the voices of psychedelic-using communities?
- PSYCHEDELIC DRUGS, MAGICAL THINKING AND PSYCHOSIS
- With great power comes great vulnerability: an ethical analysis of psychedelics’ therapeutic mechanisms proposed by the REBUS hypothesis
- Psychedelic crossings: American mental health and LSD in the 1970s
- The Well-Being Index WHO-5: hedonistic foundation and practical limitations
- Research abuses against people of colour and other vulnerable groups in early psychedelic research
- What is it to do good medical ethics? On the concepts of ‘good’ and ‘goodness’ in medical ethics
- Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial)